Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: A Study on the Relationship of Interleukin-7 Receptor Gene Polymorphisms With the Risk of Crohn's Disease Onset and the Efficacy of Infliximab
The study examined whether interleukin-7 receptor gene polymorphisms influence Crohn's disease risk and the efficacy of infliximab; the tria…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: AZD7798 Safety, Tolerability, and Pharmacokinetics After a Single Ascending and Repeat Dose Administrations to Healthy Subjects, and Patients With Crohn's Disease [Phase 1]
Phase 1 study assessing safety, tolerability, and pharmacokinetics of AZD7798 after single ascending and repeat dosing in healthy subjects a…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease [Phase 3]
A Phase 3 pediatric trial evaluating ustekinumab for moderately to severely active Crohn's disease has been completed. The study was conduct…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: A Multiple Ascending Dose Study With AGMB-129 in Healthy Participants [Phase 1]
A Phase 1 multiple ascending dose study of AGMB-129 in healthy participants has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Study of Subcutaneous HUMIRA (Adalimumab) Injection to Assess Adverse Events and Change in Disease Activity In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)
Clinical trial update reporting completion of a study evaluating subcutaneous adalimumab (Humira) in adults with moderate to severe Crohn's …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-13Clinical Trial Update: A Study of Vedolizumab in Adults With Crohn's Disease (CD)
A completed clinical trial evaluating Vedolizumab in adults with Crohn's disease has finished (NCT05192863). The study was sponsored by Take…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Digital Support for Mental Health Intervention in Patients With Inflammatory Bowel Disease [NA]
A completed clinical trial evaluated a digital mental health support intervention for patients with inflammatory bowel disease, focusing on …
-
CLINICAL_TRIALS trial_result · 2025-11-04Clinical Trial Update: Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease [Phase 3]
Phase 3 induction study of oral ozanimod for moderately to severely active Crohn's disease was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-11-03Clinical Trial Update: Rifaximin in Patients With Diabetic Gastroparesis [Phase 2]
Phase 2 clinical trial update for rifaximin in diabetic gastroparesis, sponsored by Mayo Clinic, with the study status terminated; Crohn's d…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease [Phase 3]
A Phase 3 placebo-controlled study of oral ozanimod as maintenance therapy for moderately to severely active Crohn's disease was terminated,…
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: A Study of Darvadstrocel for Treating Complex Perianal Fistulas in Children and Teenagers With Crohn's Disease [Phase 3]
A Phase 3 study evaluating darvadstrocel for complex perianal fistulas in children and teenagers with Crohn's disease was terminated, with r…
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
A South Korea–focused clinical trial update shows Vedolizumab SC is being studied in adults with moderate-to-severe Ulcerative Colitis or Cr…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases [NA]
This completed clinical trial evaluated the medico-economic impact of therapeutic drug monitoring for anti-TNF-α therapy in inflammatory bow…
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease [Phase 4]
Phase 4 clinical trial update evaluating clinical, imaging, and endoscopic outcomes in children newly diagnosed with Crohn's disease; recrui…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease [Phase 2]
Phase 2 trial update assessing the efficacy and safety of obefazimod in adults with moderately to severely active Crohn's disease; the study…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease [Phase 3]
This clinical trial update reports results from an extension Phase 3 study of oral ozanimod for moderately to severely active Crohn's diseas…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease [Phase 4]
A Phase 4 study evaluating ustekinumab (Stelara) in Chinese participants with moderately to severely active Crohn's disease has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Fasting-mimicking Diet in Treatment of Depressive Symptoms in IBD [NA]
The clinical trial evaluating a fasting-mimicking diet for depressive symptoms in inflammatory bowel disease has completed. The study includ…
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease. [Phase 3]
A Phase 3 clinical trial update evaluating subcutaneous risankizumab induction for moderately to severely active Crohn's disease, focusing o…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Implementation of Point Of Care UltraSound in the Assessment of Crohn's Disease -The POCUS Study
A clinical trial evaluating point-of-care ultrasound for assessing Crohn's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease [Phase 2]
Phase 2 trial evaluating BI 706321 in combination with ustekinumab for Crohn's disease was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: Description of the Radiological Response of Anoperineal Fistulizing Lesions of Crohn's Disease
The document reports on radiological response of anoperineal fistulizing lesions in Crohn's disease from a completed clinical trial update.
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland
A real-world study in Poland evaluating Vedolizumab for adults with ulcerative colitis or Crohn's disease has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: SMART-IBD App Trial [NA]
ClinicalTrials.gov shows the SMART-IBD app trial for inflammatory bowel disease has completed; the sponsor is Children’s Hospital Medical Ce…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Positron Emission Tomography (PET) Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Healthy Participants and Patients With Crohn's Disease [Phase 1]
Phase 1 PET imaging study evaluating changes in [11C]AZ14132516 uptake after administration of AZD7798 in healthy participants and Crohn's d…